Price close 16 Nov 2026
- 1M
- +1.5%
- 6M
- +2.6%
- YTD
- +5.2%
- 1Y
- +8.7%
- 3Y
- +46.1%
Price change over each period, from daily closes; dividends not included.
Price change over each period, from daily closes; dividends not included.
JPMorgan BetaBuilders Europe ETF (BBEU) is an europe international equity exchange-traded fund from J.P. Morgan, tracking the Morningstar Developed Europe Target Market Exposure Index.
It charges 0.09% a year — $9.00 on $10,000, and holds 361 positions, the ten largest 21.5% of the fund.
Its net assets were $9.4 billion on July 31, 2026; it is the 4th largest of the 4 europe funds among the 300 largest ETFs.
From the fund's prospectus and its latest holdings (31 Jul 2026), compiled and checked by AapWire.
| Holding | Weight | Weight bar |
|---|---|---|
| ASML Holding NV ASML | 4.58% | |
| HSBC Holdings plc HSBC | 2.62% | |
| Roche Holding AG | 2.16% | |
| Novartis AG NVS | 2.14% | |
| AstraZeneca plc AZN | 1.89% | |
| Shell plc SHEL | 1.83% | |
| Nestle SA | 1.78% | |
| Siemens AG | 1.68% | |
| Banco Santander SA | 1.46% | |
| Allianz SE | 1.36% |
| Financials | 25.7% |
|---|---|
| Health Care | 16.4% |
| Industrials | 16.1% |
| Information Technology | 10.9% |
| Consumer Staples | 10.0% |
| Energy | 7.2% |
| Materials | 4.8% |
| Utilities | 3.9% |
| Consumer Discretionary | 2.3% |
| Communication Services | 1.9% |
| Real Estate | 0.8% |
The eleven sectors of the company pages: an S&P 500 member counts in its index sector, any other holding in its industry's; shares of the stock that has a sector.
Countries as the fund reports them: GB 22.2%, CH 14.2%, FR 13.5%, DE 13.2%, NL 9.7%, ES 5.9%.
| Category | Europe · International equity |
|---|---|
| Issuer | J.P. Morgan |
| Index | Morningstar Developed Europe Target Market Exposure Index |
| Expense ratio | 0.09% · $9.00 a year on $10,000 |
| Net assets | $9.4B · 31 Jul 2026 |
| Holdings | 361 · ten largest 21.5% |
| Legal form | Registered fund |
| Rank in category | 4 of 4 · by size, among the 300 largest ETFs |
| Year | Total return |
|---|---|
| 2025 | 35.7% |
| 2024 | 2.3% |
| 2023 | 20.0% |
| 2022 | -14.7% |
| 2021 | 16.7% |
| 2020 | 5.9% |
| 2019 | 23.8% |
From the prospectus filed 25 Feb 2026.
BBEU's expense ratio is 0.09% a year, $9.00 on a $10,000 holding, from its latest prospectus.
BBEU tracks the Morningstar Developed Europe Target Market Exposure Index.
BBEU held 361 positions on July 31, 2026.
ASML Holding NV (4.6%), HSBC Holdings plc (2.6%), Roche Holding AG (2.2%), Novartis AG (2.1%), AstraZeneca plc (1.9%).
BBEU is issued by J.P. Morgan; it is a registered fund.
In the terminal
The fund's costs and returns are read from its prospectus, its positions from its latest report or its issuer's own file, and its category from what it holds and how it names itself. A figure that cannot be read is left blank. See data and methodology.